Lavior Pharma's Innovative Approach to Wound Care Wins Award
Lavior Pharma is thrilled to announce that it has received the prestigious Small Business Spotlight Award during the 2025 Business At Its Best Awards. This honor highlights their groundbreaking contributions to wound care and skincare through bio-engineered botanicals, which are not only transforming customer experiences but are also making a significant impact on healing outcomes.
Recognizing Innovation and Commitment
Co-founders Gilad Savion and Anabelle Savion have been at the forefront of merging botanical science with advanced medical approaches. Their dedication to creating clinically proven therapies reflects their commitment to changing lives. The products from Lavior are proudly manufactured in the USA and specifically designed to promote healing for those suffering from diabetes and chronic skin conditions.
Breaking New Ground in Healing
At the heart of Lavior’s innovation is the patented extract Inula viscosa AGS-RIED, a botanical that has undergone seven years of development. This unique property not only supports the immune system but also effectively addresses various stages of wound healing including inflammation, proliferation, and remodeling. Gilad Savion, CEO of Lavior Pharma, emphasized that this natural pharmaceutical is clinically proven to accelerate healing, moving chronic wounds from the inflammatory phase to recovery within just three weeks.
Lavior’s focus on scientific-backed methods establishes them as a leader in the field of wound care. Their innovative solutions work to prevent amputations and starkly enhance the quality of life for many.
The Future of Healing
Anabelle Savion, COO of Lavior, stated, "This award is a powerful recognition of our mission to improve lives through the fusion of nature and science." She highlights that the accolade reflects their ongoing dedication to quality and innovation, which is essential for the communities they serve.
The Business At Its Best Awards celebrated not only small businesses but also individuals who exemplify excellence in their fields. Esteemed industry leaders, including Paul Fitzpatrick from the U.S. Small Business Administration (SBA), underscored the importance of supporting American manufacturing, which turns out to be a common thread among the honorees.
Lavior’s recognition comes at a pivotal moment as they gear up for a significant national retail launch with Target. The company is poised to expand its product offerings while enhancing its international presence.
“Our aim is a global outreach, focusing on accessibility and affordability for our therapies,” said Gilad. Lavior is actively forming strategic partnerships and planning educational initiatives to further broaden the reach of its groundbreaking solutions.
In closing, Gilad stated, “We're building more than a company — we're building a legacy of healing.”
Frequently Asked Questions
What is Lavior Pharma known for?
Lavior Pharma specializes in bio-engineered botanical products for wound care and skincare, aimed at enhancing healing processes.
What awards has Lavior Pharma received?
Lavior Pharma received the Small Business Spotlight Award at the 2025 Business At Its Best Awards, recognizing their innovative contributions to healing.
Who are the co-founders of Lavior Pharma?
The company was co-founded by Gilad Savion and Anabelle Savion, who are dedicated to merging science and nature for healthcare advancements.
What is the significance of the patented extract Inula viscosa AGS-RIED?
This extract supports the immune system and facilitates various stages of wound healing, demonstrating significant effectiveness in clinical trials.
How is Lavior Pharma planning to expand its reach?
Lavior is preparing for a national retail launch, expanding its product line, and pursuing global opportunities to make their therapies more accessible.
